It has been shown that AR can increase expression and activity of EGFR and a protein encoded by the ERBB2 (also known as Her2) gene [96], implying androgen-mediated bladder cancer tumorigenesis and clinical progression via the regulation of the EGFR/ERBB2 pathways. The gene discussed is AR; the disease is urinary bladder carcinoma.